Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Other Operating Expenses (2020 - 2026)

Cytek Biosciences filings provide 6 years of Other Operating Expenses readings, the most recent being $13.1 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 10.59% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.4 million, a 0.66% increase, with the full-year FY2025 number at $49.4 million, up 0.66% from a year prior.
  • Other Operating Expenses hit $13.1 million in Q4 2025 for Cytek Biosciences, up from $11.7 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $13.1 million in Q4 2025 to a low of -$6.2 million in Q1 2023.
  • Median Other Operating Expenses over the past 5 years was $10.3 million (2022), compared with a mean of $7.5 million.
  • Biggest five-year swings in Other Operating Expenses: plummeted 226.69% in 2023 and later surged 375.31% in 2024.
  • Cytek Biosciences' Other Operating Expenses stood at $8.3 million in 2021, then rose by 8.73% to $9.0 million in 2022, then grew by 28.04% to $11.6 million in 2023, then grew by 2.71% to $11.9 million in 2024, then rose by 10.59% to $13.1 million in 2025.
  • The last three reported values for Other Operating Expenses were $13.1 million (Q4 2025), $11.7 million (Q3 2025), and $12.1 million (Q2 2025) per Business Quant data.